Procter & Gamble Health Share Price

P&G Health soars 15% after PAT jumps 71% YoY in December quarter results

Flows to Indian equities are at risk as investors eye China: Chris Wood

India's economic growth to exceed 6.5% in FY26, says Moody's Ratings

Delhivery, Tata: Trading strategies in stocks that hit 52-week lows

Gensol Engineering shares plunge 50% in 12 days; rating downgrades weigh

We have been informed by our Registrars and Share Transfer Agents (RTA) KFin Technologies Limited on January 272023 regarding the issuance of duplicate share certificate(s).

With reference to above captioned subject on the basis of confirmation received from our Registrar and Transfer Agent Kfin Technologies Limited ( formerly known as Kfin Technologies Private Limited) we confirm that the details of securities dematerialised during the quarter ended December 312022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to the stock exchanges where the shares of the Company are listed within the prescribed time period.We enclose herewith the copy of letter received from Kfin Technologies Limited confirming the above.

With reference to the announcement dated January 092023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday February 5 2023 inter alia to consider and approve the unaudited financial results for the quarter ended December 312022.We would like to further inform you that the Board at the said meeting would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend if declared at the Board meeting will be Monday February 13 2023.

Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2023 inter alia to consider and approve With reference to the announcement dated January 092023 and in terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is now rescheduled to be held on Sunday February 5 2023 inter alia to consider and approve the unaudited financial results for the quarter ended December 312022.We would like to further inform you that the Board at the said meeting would also consider the declaration of interim dividend for the Financial Year 2022-23. The record date for payment of the Interim dividend if declared at the Board meeting will be Monday February 13 2023.

We have been informed by our Registrars and Share Transfer Agents (RTA) KFin Technologies Limited on January 072023 regarding the loss /misplacement of the share certificate(s)